Prosecution Insights
Last updated: April 19, 2026

Neocannbio Co. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18346851 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF LUNG CANCER COMPRISING CANNABIDIOL AND ANTICANCER AGENT AS ACTIVE INGREDIENTS, AND USE THEREOF MOTEVALLI, OROD 1628 Final Rejection Jul 04, 2023

Managing Neocannbio Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month